• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

  • This publication is provided for historical reference only and the information may be out of date.

This publication is provided for historical reference only and the information may be out of date.

Cover of Effect of Supplemental Antioxidants Vitamin C, Vitamin E, and Coenzyme Q10 for the Prevention and Treatment of Cardiovascular Disease

Effect of Supplemental Antioxidants Vitamin C, Vitamin E, and Coenzyme Q10 for the Prevention and Treatment of Cardiovascular Disease

Evidence Reports/Technology Assessments, No. 83

Program Directors: , MD, PhD and , PhD. Project Director: , MD.

Rockville (MD): Agency for Healthcare Research and Quality (US); .
Report No.: 03-0043ISBN-10: 1-58763-090-7

Structured Abstract

Objectives:

The purpose of this study was to conduct a systematic review of the scientific literature to identify and assess the evidence for the efficacy of the antioxidant supplements vitamin C, vitamin E, and coenzyme Q10 for the prevention and treatment of cardiovascular disease or modification of known risk factors for cardiovascular disease. It was our intention to perform meta-analyses where possible. The results may be used to develop a research agenda as well as to assist clinicians in advising patients who desire to take antioxidants to modify their risk of cardiovascular disease.

Search Strategy:

A comprehensive search was conducted for citations in English and other languages using 15 databases. We used the search terms antioxidant, vitamin E, vitamin C, coenzyme Q10, and all pharmacologic synonyms in combination with the MeSH term cardiovascular disease. We also identified appropriate literature by searching the bibliographies of review articles and asking our experts for articles.

Selection Criteria:

The literature search was confined to controlled trials assessing supplements of the three antioxidants—vitamin E, vitamin C, and coenzyme Q10—and cardiovascular disease. Cardiovascular disease included coronary artery disease and its sequelae as well as stroke, heart failure, and peripheral vascular disease. Primary emphasis was given to studies reporting clinical outcomes such as mortality or myocardial infarction. Studies were also included if they affected risk factors for cardiovascular disease such as blood lipids or hypertension. Language of publication was not a barrier to inclusion.

Data Collection and Analysis:

Information was collected about trial design and quality, number and characteristics of patients, details on the intervention, and time between intervention and outcome measurement. Two physicians independently reviewed each article, abstracted data, and resolved differences by consensus. Data were synthesized qualitatively or quantitatively as appropriate. For this report, pooled analysis was performed of the effects of vitamin E alone and in combination on death, myocardial infarction, and blood lipid levels.

Main Results:

Our literature search process identified 156 articles that represented results from 159 reports on 144 unique trials (i.e., those reporting data not duplicated in another publication). Of the 159 reports, one-third were judged to be of high quality using the Jadad method.

Studies reporting on the outcomes of death, myocardial infarction, and/or blood lipid levels were selected for further analysis. For the interventions of vitamin E alone and in combination with other antioxidants, sufficient numbers of studies existed to perform pooled analysis.

Both the pooled analyses of smaller studies and the results of larger studies did not show, in general, any beneficial effect of vitamin E supplementation on cardiovascular outcomes. Some trials reported beneficial effects on only one outcome or in subgroups, but these results were either not confirmed or were contradicted by other studies.

We did not find evidence in the pooled analysis of smaller trials that vitamin E alone or in combination had a significant effect on levels of TC, LDL, or HDL. For the Heart Prevention Study, a small increase in LDL and HDL was reported.

We identified one meta-analysis of the effect of coenzyme Q10 that reported mostly beneficial effects on measures of cardiac function in patients with heart failure. Five placebo-controlled, randomized studies that measured clinically relevant outcomes, enrolled at least 60 patients, and had at least 6 months duration of treatment were identified and reported mixed results.

Four studies were identified that assessed the effect of vitamin C (mostly in combination with other antioxidants) on clinical outcomes in patients with or at high risk for cardiovascular disease using a placebo-controlled, randomized design, enrolling at least 60 patients, and having at least 6 months duration of treatment. The results were uniformly negative.

Conclusions:

For the combinations and conditions studied, the pooled analysis of smaller studies does not show evidence of an effect of vitamin E alone or in combination with other agents on all-cause mortality, cardiovascular mortality, fatal or nonfatal MI, or blood lipid levels. Results from a number of large clinical trials not included in the pooled analysis were substantially in agreement with this conclusion. Large studies of vitamin C in combination with other antioxidants for the prevention of cardiovascular disease reported no favorable outcomes. There is no convincing evidence either supporting or refuting the value of coenzyme Q10 in cardiovascular disease.

Contents

540 Gaither Road, Rockville, MD 20850. www​.ahrq.gov

Project Director: Ian Coulter, PhD. Physician Reviewers: Jay Udani, MD, Myles Spar, MPH, MD, Karen Oda, MD. Programmer/Analyst: Lara K Jungvig, BA. Statisticians: Wenli Tu, MS, Marika J Suttorp, MS. Staff Assistants: Di Valentine, JD, Louis Ramirez, BA. Reference Librarian: Roberta Shanman, MLS. Editor: Sydne J Newberry, PhD.

Prepared for: Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.1 Contract No. 290-97-0001, Task Order No. 06. Prepared by: Southern California-RAND Evidence-based Practice Center, Santa Monica, California.

Suggested citation:

Shekelle P, Morton S, Hardy M. Effect of Supplemental Antioxidants Vitamin C, Vitamin E, and Coenzyme Q10 for the Prevention and Treatment of Cardiovascular Disease. Evidence Report/Technology Assessment No. 83 (Prepared by Southern California-RAND Evidence-based Practice Center, under Contract No 290-97-0001). AHRQ Publication No. 03-E043. Rockville, MD: Agency for Healthcare Research and Quality. July 2003.

This report may be used, in whole or in part, as the basis for development of clinical practice guidelines and other quality enhancement tools, or a basis for reimbursement and coverage policies. AHRQ or U.S. Department of Health and Human Services endorsement of such derivative products may not be stated or implied.

AHRQ is the lead Federal agency charged with supporting research designed to improve the quality of health care, reduce its cost, address patient safety and medical errors, and broaden access to essential services. AHRQ sponsors and conducts research that provides evidence-based information on health care outcomes; quality; and cost, use, and access. The information helps health care decisionmakers—patients and clinicians, health system leaders, and policymakers—make more informed decisions and improve the quality of health care services.

The authors of this report are responsible for its content. Statements in the report should not be construed as endorsement by the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Services of a particular drug, device, test, treatment, or other clinical service.

1

540 Gaither Road, Rockville, MD 20850. www​.ahrq.gov

Bookshelf ID: NBK37059
PubReader format: click here to try

Views

  • PubReader
  • Print View
  • Cite this Page

See also

Related citations in PubMed

See reviews...See all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...